The data about the role of TAM-expressing SR-B1 in cancer are limited, but SR-B1 expression was found in head and neck cancer, lung cancer, prostate cancer and breast cancer, where it positively correlates with the tumor aggressiveness and poor prognosis (82, 87, 88). This evidence concerns the gene SCARB1 and lung carcinoma.